nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ATP6AP2—Parkinson's disease	0.0683	0.153	CbGpPWpGaD
Fludrocortisone—NR3C2—hindbrain—Parkinson's disease	0.047	0.0926	CbGeAlD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0374	0.0839	CbGpPWpGaD
Fludrocortisone—NR3C1—nerve—Parkinson's disease	0.0337	0.0663	CbGeAlD
Fludrocortisone—NR3C2—brainstem—Parkinson's disease	0.0269	0.0531	CbGeAlD
Fludrocortisone—NR3C2—forebrain—Parkinson's disease	0.026	0.0512	CbGeAlD
Fludrocortisone—NR3C1—hindbrain—Parkinson's disease	0.0252	0.0497	CbGeAlD
Fludrocortisone—NR3C2—cardiovascular system—Parkinson's disease	0.022	0.0433	CbGeAlD
Fludrocortisone—AR—Nuclear Receptors—NR4A2—Parkinson's disease	0.022	0.0493	CbGpPWpGaD
Fludrocortisone—AR—forebrain—Parkinson's disease	0.0193	0.0379	CbGeAlD
Fludrocortisone—NR3C2—medulla oblongata—Parkinson's disease	0.0188	0.037	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0174	0.0389	CbGpPWpGaD
Fludrocortisone—NR3C2—midbrain—Parkinson's disease	0.0172	0.0338	CbGeAlD
Fludrocortisone—NR3C2—spinal cord—Parkinson's disease	0.0168	0.033	CbGeAlD
Fludrocortisone—NR3C1—Nuclear Receptors—NR4A2—Parkinson's disease	0.0167	0.0374	CbGpPWpGaD
Fludrocortisone—AR—cardiovascular system—Parkinson's disease	0.0163	0.0321	CbGeAlD
Fludrocortisone—NR3C1—embryo—Parkinson's disease	0.0158	0.0311	CbGeAlD
Fludrocortisone—NR3C2—head—Parkinson's disease	0.0149	0.0293	CbGeAlD
Fludrocortisone—NR3C1—brainstem—Parkinson's disease	0.0145	0.0285	CbGeAlD
Fludrocortisone—NR3C2—nervous system—Parkinson's disease	0.0141	0.0278	CbGeAlD
Fludrocortisone—NR3C1—forebrain—Parkinson's disease	0.014	0.0275	CbGeAlD
Fludrocortisone—NR3C2—central nervous system—Parkinson's disease	0.0136	0.0268	CbGeAlD
Fludrocortisone—NR3C2—cerebellum—Parkinson's disease	0.0133	0.0262	CbGeAlD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0132	0.0295	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—INSR—Parkinson's disease	0.0131	0.0293	CbGpPWpGaD
Fludrocortisone—Testosterone Propionate—COMT—Parkinson's disease	0.0127	0.276	CrCbGaD
Fludrocortisone—AR—spinal cord—Parkinson's disease	0.0124	0.0244	CbGeAlD
Fludrocortisone—NR3C1—cardiovascular system—Parkinson's disease	0.0118	0.0232	CbGeAlD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—Parkinson's disease	0.0117	0.0262	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PARK7—Parkinson's disease	0.0111	0.0249	CbGpPWpGaD
Fludrocortisone—AR—head—Parkinson's disease	0.011	0.0217	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.011	0.0247	CbGpPWpGaD
Fludrocortisone—NR3C2—brain—Parkinson's disease	0.0108	0.0213	CbGeAlD
Fludrocortisone—AR—nervous system—Parkinson's disease	0.0105	0.0206	CbGeAlD
Fludrocortisone—NR3C1—medulla oblongata—Parkinson's disease	0.0101	0.0198	CbGeAlD
Fludrocortisone—AR—central nervous system—Parkinson's disease	0.0101	0.0198	CbGeAlD
Fludrocortisone—NR3C1—midbrain—Parkinson's disease	0.00921	0.0181	CbGeAlD
Fludrocortisone—NR3C1—spinal cord—Parkinson's disease	0.00899	0.0177	CbGeAlD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00836	0.0187	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00835	0.0187	CbGpPWpGaD
Fludrocortisone—AR—brain—Parkinson's disease	0.00799	0.0157	CbGeAlD
Fludrocortisone—NR3C1—head—Parkinson's disease	0.00799	0.0157	CbGeAlD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PENK—Parkinson's disease	0.00775	0.0174	CbGpPWpGaD
Fludrocortisone—NR3C1—nervous system—Parkinson's disease	0.00757	0.0149	CbGeAlD
Fludrocortisone—NR3C1—central nervous system—Parkinson's disease	0.00729	0.0144	CbGeAlD
Fludrocortisone—NR3C1—cerebellum—Parkinson's disease	0.00713	0.014	CbGeAlD
Fludrocortisone—AR—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.00693	0.0155	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.00692	0.0155	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00646	0.0145	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00633	0.0142	CbGpPWpGaD
Fludrocortisone—NR3C1—brain—Parkinson's disease	0.00579	0.0114	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00543	0.0122	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00521	0.0117	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PRKRA—Parkinson's disease	0.00442	0.0099	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—INS—Parkinson's disease	0.00437	0.0098	CbGpPWpGaD
Fludrocortisone—Megestrol acetate—ABCB1—Parkinson's disease	0.00423	0.0918	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TH—Parkinson's disease	0.00418	0.00938	CbGpPWpGaD
Fludrocortisone—Testosterone—MAOA—Parkinson's disease	0.00416	0.0902	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00412	0.00923	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00408	0.00914	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00395	0.00886	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Parkinson's disease	0.00395	0.00886	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00351	0.00786	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00338	0.00759	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00337	0.00757	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00332	0.00745	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00332	0.00743	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.00329	0.00738	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—ABCB1—Parkinson's disease	0.00324	0.0703	CrCbGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Parkinson's disease	0.00313	0.00701	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NR4A2—Parkinson's disease	0.00311	0.00698	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TAF1—Parkinson's disease	0.00311	0.00698	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.003	0.00672	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00291	0.00653	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00291	0.00651	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00266	0.00596	CbGpPWpGaD
Fludrocortisone—Spironolactone—ABCB1—Parkinson's disease	0.00263	0.0571	CrCbGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00258	0.00578	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00256	0.00574	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Parkinson's disease	0.00252	0.00566	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00252	0.00565	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPL6—Parkinson's disease	0.00249	0.00558	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2E1—Parkinson's disease	0.00248	0.0539	CrCbGaD
Fludrocortisone—Prednisone—ABCB1—Parkinson's disease	0.00248	0.0538	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00247	0.00553	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00245	0.0055	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00237	0.00531	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—Parkinson's disease	0.00229	0.0496	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00228	0.0051	CbGpPWpGaD
Fludrocortisone—Betamethasone—ABCB1—Parkinson's disease	0.00224	0.0486	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.0022	0.00494	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.0021	0.00471	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PRKRA—Parkinson's disease	0.00205	0.00459	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00204	0.00458	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00201	0.00451	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.002	0.00448	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP2D6—Parkinson's disease	0.00199	0.0433	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00198	0.00444	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00196	0.00438	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPL23A—Parkinson's disease	0.00189	0.00423	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPL14—Parkinson's disease	0.00189	0.00423	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00186	0.00417	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2D6—Parkinson's disease	0.00182	0.0396	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.0018	0.00403	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00179	0.004	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPS8—Parkinson's disease	0.00176	0.00394	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—Parkinson's disease	0.00175	0.0379	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00159	0.00357	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PRKRA—Parkinson's disease	0.00155	0.00349	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00152	0.0034	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR4A2—Parkinson's disease	0.00144	0.00324	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TAF1—Parkinson's disease	0.00144	0.00324	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—Parkinson's disease	0.00142	0.0309	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—HSPA8—Parkinson's disease	0.00141	0.00316	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CTGF—Parkinson's disease	0.0014	0.00314	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—INS—Parkinson's disease	0.00139	0.00313	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Parkinson's disease	0.00138	0.00309	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00135	0.00303	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—Parkinson's disease	0.00135	0.0292	CrCbGaD
Fludrocortisone—Dexamethasone—ABCB1—Parkinson's disease	0.0013	0.0283	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—HSPA1A—Parkinson's disease	0.00128	0.00288	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00121	0.00272	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00118	0.00266	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00118	0.00265	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPL6—Parkinson's disease	0.00115	0.00259	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NR4A2—Parkinson's disease	0.0011	0.00246	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TAF1—Parkinson's disease	0.0011	0.00246	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00103	0.0023	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.00101	0.00225	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000999	0.00224	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000924	0.00207	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000899	0.00202	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000897	0.00201	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.000881	0.00197	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL6—Parkinson's disease	0.000876	0.00196	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPL23A—Parkinson's disease	0.000875	0.00196	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPL14—Parkinson's disease	0.000875	0.00196	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00086	0.00193	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPS8—Parkinson's disease	0.000816	0.00183	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—Parkinson's disease	0.000755	0.00169	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000731	0.00164	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000694	0.00156	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL14—Parkinson's disease	0.000664	0.00149	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL23A—Parkinson's disease	0.000664	0.00149	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPA8—Parkinson's disease	0.000654	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000652	0.00146	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CTGF—Parkinson's disease	0.000651	0.00146	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPS8—Parkinson's disease	0.000619	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—Parkinson's disease	0.000609	0.00137	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPA1A—Parkinson's disease	0.000595	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000526	0.00118	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPA8—Parkinson's disease	0.000496	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CTGF—Parkinson's disease	0.000494	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	0.000452	0.00101	CbGpPWpGaD
